Abstract
There are currently multiple approaches that are effective in patients initiating antiretroviral therapy Recommended treatment choices are based on a dual combination 'backbone' consisting of two nucleoside reverse transcriptase inhibitors plus a protease inhibitor or non-nucleoside reverse transcriptase inhibitor. A novel approach being studied is a regimen that consists of three nuclesides only. Therapeutic decisions need to encompass a long-term strategy that is individualized and likely to provide optimal viral suppression that is tolerable as well as effective.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 172-176 |
| Number of pages | 5 |
| Journal | International Antiviral News |
| Volume | 7 |
| Issue number | 12 |
| State | Published - Dec 1 1999 |
ASJC Scopus subject areas
- Pharmacology
- Virology